Patents Assigned to Anergis, S.A.
  • Allergen peptide fragments and use thereof
    Patent number: 7923209
    Abstract: The present invention relates generally to in vivo methods and compositions designed for allergen specific immunotherapy. The compositions include contiguous overlapping peptide fragments which together form an entire amino acid sequence of an allergen.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: April 12, 2011
    Assignee: Anergis, S.A.
    Inventors: Francois Spertini, Blaise Corthesy